Engflag

Isoconazole Nitrate

Quick links to important sections

Isoconazole Nitrate

Isoconazole Nitrate_DE

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isoconazole Nitrate

Property Description
Active Ingredient Isoconazole Nitrate (INN)
Pharmacological Class Broad-Spectrum Antifungal (Imidazole Derivative)
Origin / Type Synthetic Compound
Primary Forms Topical creams, solutions, and vaginal ovules/pessaries
Route Topical (Dermal or Vaginal)

What Type of Medicine is Isoconazole Nitrate?

Isoconazole Nitrate is a potent, synthetic antifungal agent classified pharmacologically as an imidazole derivative, effective against a wide range of superficial fungal infections. The compound is classified under the Anatomical Therapeutic Chemical (ATC) codes D01AC05 and G01AF07, which identify its use as an antifungal for topical and gynecological purposes.

As the stable nitrate salt of the base compound, Isoconazole, it serves as the single active ingredient in its typical formulations, distinguishing it as a foundational antimycotic medicine. This synthetic compound exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds, which are common causes of superficial mycoses. Pharmacological data indicates that this class of drugs is clinically recognized for its efficacy in clearing infections in adults.

Composition, Origin, and Available Forms

Isoconazole Nitrate is chemically synthesized for stability and is formulated into preparations tailored for local application to the skin or mucous membranes. The compound is the active component (INN) and is categorized as a derivative of the imidazole structure. The drug's presentation determines its route of administration, which is strictly topical (cutaneous) or vaginal. For patient use, the drug is typically available as various topical preparations, including creams (which are emulsions) and solutions for application to the skin, as well as specialized ovules or pessaries for vaginal use. This dual availability—dermal and vaginal—is a key differentiating factor, positioning it for treating conditions like tinea infections on the skin and localized candida infections.

General Purpose and High-Level Action

The general purpose of Isoconazole Nitrate is to control and eliminate fungal proliferation by targeting the structural components of the fungal cell membrane. The drug achieves this benefit by interfering with the synthesis of ergosterol, a sterol essential for maintaining the permeability and integrity of the fungal cell wall. By disrupting this vital process, the antifungal agent exhibits both fungistatic activity (inhibiting growth) and fungicidal activity (killing the organism) to effectively clear the pathogens responsible for superficial mycoses. This mechanism of action provides a predictable therapeutic effect for managing common infections.

Regulatory References

  1. NIH MeSH: Antifungal Agents (D000958)

What side effects are possible with Isoconazole Nitrate?

Possible Side Effects and Safety Information

The safety profile for Isoconazole Nitrate, in its topical and vaginal formulations, is primarily characterized by localized reactions at the application site. Regulatory documents classify the most commonly reported adverse reactions under the General disorders and administration site conditions and Skin and sub-cutaneous tissue disorders categories.

Reported adverse reactions, derived from clinical study summaries, frequently include a burning sensation, irritation, pruritus (itching), and erythema (redness) at the site of application. For vaginal preparations, local reactions such as vaginal pain, swelling sensation, or a sensation of heat are commonly documented. Other reactions, such as the appearance of vesicles (blisters), are occasionally noted.

Safety Considerations and Restrictions

Isoconazole Nitrate is formally contraindicated in individuals with a known hypersensitivity to the active ingredient or to any of the formulation's excipients. Regulatory labeling also notes that certain excipients, such as cetostearyl alcohol in creams, may be associated with localized dermal reactions.

Specific safety statements address use in vulnerable populations:

  • Pregnancy: Use is generally advised to be avoided during the first trimester, and treatment throughout the remainder of the pregnancy requires careful assessment of the clinical benefits.
  • Lactation: Nursing mothers should avoid applying the drug to the breast area, and the risk to the infant is considered when advising on use during breast-feeding.
  • Neonates: The possibility of adverse reactions in neonates is noted if the mother received extensive treatment during pregnancy or lactation.

These safety classifications reflect the drug's minimal systemic absorption and ensure that the risk of even localized or low-level systemic effects in sensitive populations is officially acknowledged.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Isoconazole Nitrate, a topical antifungal agent, addresses overdose primarily within the context of accidental exposure.

Documented Overdose Risk and Manifestations

Regulatory assessments based on acute toxicity studies indicate that no risk of acute systemic intoxication is expected following a single dermal application of an overdose (applying too much cream over a large area) or inadvertent oral ingestion of the topical formulation. Due to the low rate of systemic absorption from the skin, the prescribing information documents no reported cases of poisoning in humans.

Excessive topical use may result in local adverse reactions, such as skin irritation (e.g., pruritus or burning sensation) at the application site, but these are generally considered local effects rather than signs of acute systemic overdose.

Required Emergency Actions

Despite the low expected systemic risk, immediate procedural action is required for accidental exposure:

  • When to Seek Immediate Medical Help: Immediate medical attention or consultation is required if the product is inadvertently swallowed. Individuals should contact a Poison Center or doctor if they feel unwell after exposure.
  • Supportive Management: Management of accidental ingestion primarily involves supportive and symptomatic treatment, as no specific antidote is known or documented. Medical observation for at least 48 hours is recommended following acute exposure due to the potential for delayed symptoms.

Therapeutic Uses of Isoconazole Nitrate

What Isoconazole Nitrate Treats: Main Uses and Benefits

The primary therapeutic application of Isoconazole Nitrate involves providing supportive relief by targeting conditions involving fungal pathogens. The drug is relevant for conditions presenting with systemic or localized discomfort.

Addressing Common Fungal Infections of the Skin

This medication is generally used to treat dermatomycoses, specifically fungal infections caused by dermatophytes and yeasts. It is relevant for common clinical scenarios such as athlete's foot (Tinea pedis), jock itch (Tinea cruris), and ringworm (Tinea corporis), and may assist with managing the infectious process while supporting general well-being during symptomatic phases.

“The medication is commonly used to help with conditions presenting with disruptive symptom manifestations.”

Providing Relief from Burning and Inflammatory Discomfort

Isoconazole Nitrate supports the management of acute symptoms like intense pruritus (itching), burning sensations, and localized erythema (redness). Applied in conditions where patients experience these manifestations, it helps ease the overall burden of these distressing sensory symptoms, contributing to easing the overall symptom load.

Quick Fact: Relevant for Easing Pruritus and Erythema

Management of Vulvovaginal Candidiasis and Complicated Skin Cases

The drug is applied across domains where additional symptomatic support is needed, including the treatment of symptomatic episodes of vulvovaginal candidiasis (vaginal thrush), addressing associated discomfort and discharge. It also plays a role in managing cutaneous infections with pronounced inflammation or where a Gram-positive bacterial co-infection is present, providing supportive relief in challenging symptomatic phases.

Regulatory References

  1. Philippine FDA Verification Portal

Eligibility and Restrictions for Use

The eligibility profile for Isoconazole Nitrate is defined by strict regulatory requirements detailing who can and cannot use the topical or vaginal preparation, based on patient sensitivity and local infectious status.

Absolute Contraindications

The medicine is strictly contraindicated for any individual with a known hypersensitivity to the active substance, Isoconazole Nitrate, or to any of the product's excipients. Use is also prohibited if specific non-fungal infections are present in the area to be treated, including tuberculous or syphilitic processes, or if there is an active viral disease such as varicella or herpes zoster. Certain conditions like rosacea and perioral dermatitis in the treatment area also define non-eligibility.

Conditional and Restricted Use

Population Official Regulatory Status
Pregnancy (First Trimester) Use should be avoided.
Lactation Must not be applied to the breasts of nursing women.
Children (< 2 years) Not recommended due to limited safety data on systemic absorption.
Adults & Geriatric Established use; no specific dose adjustment required.

This official structure confirms established eligibility for adults and older children while clearly limiting use based on pre-existing conditions and physiological status.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Isoconazole Nitrate is a topical antifungal agent, and official regulatory documentation indicates a limited potential for systemic drug-drug interactions due to minimal absorption through the skin. Government drug labels often state that no interactions with other medicinal products have been documented for this reason.

Local Product-Type Restrictions

Although systemic interactions are not documented, a critical local interaction concerns the excipients present in the topical and vaginal formulations. Certain cream and ovule preparations contain liquid paraffin and soft paraffin (petrolatum) as inactive ingredients.

Latex Barrier Contraceptives: The official regulatory restriction concerns the co-administration of Isoconazole Nitrate formulations with latex products such as condoms and diaphragms in the genital region. The paraffin excipients are documented to cause damage to the latex material, which can subsequently reduce the mechanical strength and effectiveness of these barrier contraceptives. This restriction constitutes a mandatory constraint on co-use in the application area to maintain the physical integrity of the protective device.

Officially Documented Interaction Profile Summary:

Interaction Type Status in Regulatory Documents
Systemic Drug-Drug Not documented/No studies performed
Food, Alcohol, Supplements Not documented
Local Product-Type Restriction Damages latex barrier contraceptives

This profile is defined by the drug's topical route, with the primary constraint being a physical compatibility issue rather than a typical pharmacological interaction.

Mechanism of Action

How Isoconazole Nitrate Works: Mechanism of Action

Inhibition of the Fungal Ergosterol Pathway

Isoconazole nitrate's primary action involves the targeted inhibition of lanosterol 14alpha-demethylase (CYP51), a fungal-specific enzyme essential for synthesizing ergosterol, the key structural component of the fungal cell membrane. The drug achieves this by binding to the enzyme's heme iron. Blocking this pathway leads to the accumulation of toxic precursor sterols and a critical loss of membrane integrity. This process compromises the functional fluidity and structural integrity of the fungal cell membrane, leading to the inhibition of growth or cell lysis.

Dual Action: Membrane Disruption and Antimicrobial Scope

Beyond its enzyme-blocking role, Isoconazole nitrate exerts a direct, disruptive effect on the fungal membrane and possesses activity against certain Gram-positive bacteria, an action linked to generating reactive oxygen species. The direct membrane action contributes to a concentration-dependent fungicidal effect. This dual capability results in an antimicrobial spectrum that includes both fungal and susceptible Gram-positive bacterial pathogens, leading to a significant reduction in the microbial burden.

Dosage and Administration Information

The administration of Isoconazole Nitrate is structured around its specific topical (cutaneous) and vaginal routes of application. Standard protocols establish the precise dosing frequency and total course duration, which varies by formulation and site of use.

The available forms include a cream (typically 1%) for dermal application and vaginal ovules/suppositories (up to 600 mg strength) for localized treatment.

Official Administration Guidelines

Instruction Category Official Guideline
Route of Administration Cutaneous (Topical) and Vaginal.
Dosing Frequency The cream is applied once or twice daily. The vaginal ovules are used as a single-day treatment (600 mg dose) or in a multi-day course.
Course Duration Rule Topical: Treatment duration may range from two to four weeks. If used in combination with a corticosteroid, the course must not exceed two weeks.
Special Procedural Conditions The vaginal ovule must be inserted deep into the vagina. The preparation is strictly not an oral agent. In case of a missed dose, it should be applied as soon as possible, but two doses must never be administered at one time.
Age-Group Rules Dose adjustments are generally not required for children aged 2 years and older and adolescents using the topical combination product.

Connection to the Overall Use Protocol

Established guidelines define the official use protocol as a route-specific, time-bound application designed for non-systemic delivery. This structure prescribes precise frequency and defined course durations for both the cutaneous and vaginal forms, establishing that administration is strictly local and procedural.

Recent Clinical Evidence

Isoconazole Nitrate: Recent Clinical Evidence

Isoconazole nitrate is an imidazole-class antifungal agent investigated for the management of superficial skin and mucosal fungal infections caused by dermatophytes, yeasts, molds, and specific Gram-positive bacteria.

Efficacy and Antimicrobial Spectrum

Clinical studies have explored the agent's effectiveness in conditions such as tinea infections (e.g., tinea inguinalis) and vaginal candidiasis. In assessments for vaginal candidiasis, single-dose administration of isoconazole nitrate has been associated with high clinical and mycological cure rates in the range of 80–90%.

Beyond its core fungicidal properties, research has also assessed the drug's activity against Gram-positive bacteria, including certain strains of Staphylococcus aureus and Propionibacterium acnes, suggesting a broad antimicrobial profile relevant to mixed superficial skin infections.

Combination Therapy and Symptom Relief

Isoconazole nitrate is also frequently studied in combination with topical corticosteroids, such as diflucortolone valerate. Comparative studies on inflammatory dermatomycoses (like tinea inguinalis) evaluated whether this combination provided differences in symptomatic improvement. In these trials, the combination was observed to have a faster onset of effects related to symptoms like erythema (redness) and pruritus (itching) compared to antifungal monotherapy. Mycological cure rates across treatment groups remained similar.

Safety Profile and Tolerability

In various clinical settings, topical formulations of isoconazole nitrate have generally been well-tolerated. The most commonly reported side effects at the site of application are typically mild and transient, including local stinging, itching, or redness. Systemic absorption following topical application is minimal, contributing to a generally favorable safety profile observed in trials.

Key Studies & References

  1. Topical Antifungal Agents: An Overview of Available Options for Cutaneous Dermatophytosis

Frequently Asked Questions (FAQ)

Common questions about Isoconazole Nitrate (FAQ)

Q: How quickly do people typically begin to see relief or improvement?

Official reports from clinical studies indicate that symptom relief, such as the reduction of itching and redness, has been observed to start relatively quickly, especially when Isoconazole Nitrate is used in a combination product that also contains a corticosteroid. For the monotherapy product (Isoconazole Nitrate alone), improvement times can vary based on the specific type of fungal infection and the individual patient’s response to the treatment.

Q: Is there a higher risk of side effects if the medication is used for a long period?

According to official product information, using the medication for prolonged periods or applying it over large areas of the skin can potentially increase the risk of localized side effects. This general caution is an important factor in defining the maximum recommended treatment duration outlined in the administration guidelines.

Q: What are the non-active ingredients in the cream/lotion base?

The non-active components, also known as excipients, in a typical Isoconazole Nitrate cream formulation include substances like soft paraffin, liquid paraffin, and cetostearyl alcohol. These ingredients help to form the cream’s base and facilitate its application. Official documents list these excipients because it is noted that use of the product is generally contraindicated for individuals with known sensitivities to these excipients.

Q: What are the warning signs of a severe or serious reaction to Isoconazole Nitrate?

Regulatory documents describe signs of a severe reaction that warrant attention, which may include severe irritation at the application site or a generalized hypersensitivity reaction. Symptoms noted in the product information include swelling of the face, lips, or throat, or the development of a widespread rash, which are symptoms associated with serious events.

Q: What is the function of the 'nitrate' part of the drug name?

Isoconazole Nitrate is chemically known as the nitrate salt of the base compound, Isoconazole. This salt form is selected by manufacturers because it contributes to the overall stability and solubility of the active ingredient. This chemical modification is intended to help optimize the penetration and effectiveness of the medicine when it is applied topically.

Q: Is the use of Isoconazole Nitrate documented for yeast infections besides Candida?

Regulatory information confirms the antimicrobial scope of Isoconazole Nitrate includes species beyond Candida. Official documents indicate that the drug is effective against a variety of yeasts and yeast-like fungi. This includes organisms responsible for common conditions such as Pityriasis Versicolor (or tinea versicolor), which is caused by the Malassezia yeast genus.

Q: What should I do if the medication accidentally gets into my eye or mouth?

Official warnings state that contact with sensitive mucous membranes, including the eyes and mouth, should be strictly avoided. If accidental contact occurs, the affected area may be rinsed immediately with copious amounts of water. If continued irritation or discomfort persists after rinsing, official guidelines note this as a condition where medical advice may be sought.

Q: Can I use other creams or lotions on the same area?

Official patient guidelines include a general caution regarding the concurrent use of multiple topical products on the same area. Applying other creams or lotions may increase the risk of local skin reactions or potentially interfere with the medicine’s absorption or effectiveness. This general constraint on co-administration is noted in the product guidelines.

Q: Is it possible for a fungal infection to return after completing the full course of treatment?

Regulatory patient information addresses the potential for re-infection, or relapse, after completing the prescribed treatment course. Therefore, product guidelines often include associated recommendations for maintaining personal hygiene or sterilizing items like linen and towels. These preventative measures are noted to help reduce the risk of the infection returning.

Q: Are there special considerations for using Isoconazole Nitrate on very large areas of the body?

Yes, official warnings note special considerations for application quantity and area size. Application over very large surface areas or using occlusive dressings (airtight bandages) can increase the absorption of the medicine into the body. This caution is intended to manage the risk of possible low-level systemic side effects.

How should Isoconazole Nitrate be stored and disposed of?

How to Store and Dispose of Isoconazole Nitrate

The storage of isoconazole nitrate must strictly adhere to the conditions documented in official regulatory labeling to maintain product stability.

Mandatory Storage Conditions

Isoconazole nitrate must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). It is mandatory to protect from freezing and to store the product away from excessive heat or direct sunlight.

Protection and Handling

The medicine should be kept in its original container, which must be tightly closed to protect the contents from moisture and light. A crucial safety requirement is to store the product out of the reach and sight of children.

Disposal Instructions

Any unused or expired product must be disposed of in accordance with local regulations and pharmacy guidelines. To prevent environmental contamination, the medicine should not be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Isoconazole Nitrate found in:

A-Z Index: